Evidence map›Paper›PMID 12107110›Full record

ArticleThe American journal of pathology2002

Eosinophil recruitment in type-2 hypersensitivity pulmonary granulomas: source and contribution of monocyte chemotactic protein-3 (CCL7).

Xiao-Zhou Shang, Bo-Chin Chiu, Valerie Stolberg, Nicholas W Lukacs, Steven L Kunkel, Hedwig S Murphy, Stephen W Chensue

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Therapeutic Targets in Allergic Conjunctivitis.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  8. Article
  9. Review
  10. Review
  11. Cytokine Panels and Pediatric Acute Respiratory Distress Syndrome: A Translational Investigation.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2020
    Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xiao-Zhou ShangDepartment of Pathology, University of Michigan Hospitals, Ann Arbor, USA.
Bo-Chin Chiu
Valerie Stolberg
Nicholas W Lukacs
Steven L Kunkel
Hedwig S Murphy
Stephen W Chensue
University of Michigan–Ann Arbor · USVeterans Health Administration · US

Funding

CHEMOKINE RECEPTOR DYNAMICS IN GRANULOMA FORMATIONR01AI043460 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENSUE, STEPHEN W · 1998 to 2013
$2.3M
SUPPLY SCHISTOSOME INFECTED SNAILS &MAMMALSN01AI055270 · NIAID · BIOMEDICAL RESEARCH INSTITUTE · PI LEWIS, FRED A · 1995 to 2000
$560k
Chemokine Receptor Dynamics in Granuloma FormationR56AI043460 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENSUE, STEPHEN W · 2008 to 2008
$252k
The Effects of HAART on Cancer Incidence in AIDS CasesR03AI055270 · NIAID · SAN FRANCISCO DEPT OF PUBLIC HEALTH · PI SCHEER, SUSAN · 2003 to 2004
$85k
NIAID NIH HHS AI43460NIAID NIH HHS N01-AI-55270NIAID NIH HHS R01 AI043460NIAID NIH HHS R03 AI055270NIAID NIH HHS R56 AI043460
6 · The paper itself

Abstract

Monocyte chemotactic protein-3 (MCP-3/CCL7) has potent eosinophil chemoattractant properties. The present study determined its relative contribution to the formation of Th2 cytokine-mediated (type-2) eosinophil-rich interstitial lung granulomas induced by antigens of Schistosoma mansoni eggs. Both MCP-3 transcripts and protein levels were more strongly expressed in lungs with type-2 than with type-1 (mycobacterial antigen-elicited Th1-mediated) granulomas. In vivo treatment with neutralizing antibodies demonstrated that MCP-3 abrogated eosinophil accumulation in type-2 lesions by 40 to 50%. Immunohistochemical staining revealed that MCP-3 localized to vessels in or near granulomas suggesting that endothelial cells were an important in situ source of MCP-3. Maximal MCP-3 transcript expression was abrogated by anti-interleukin-4 treatment. Furthermore, cultured mouse lung endothelial cells displayed augmented MCP-3 production in response to interleukin-4. Together, these results suggest that MCP-3 contributes to a significant component of eosinophil recruitment in the type-2 interstitial granuloma formation and Th2 cytokines promote its production.

Indexed as

CytokinesAnimalsAntibodiesAntigens, HelminthBlood VesselsCell MovementChemokine CCL7Endothelium, VascularEosinophilsFemaleGranuloma, Respiratory TractHypersensitivityInterleukin-4LungLung DiseasesMiceAntibodiesAntigens, HelminthCcl7 protein, mouseChemokine CCL7CytokinesInterleukin-4Monocyte Chemoattractant Proteins

Identifiers

PMID12107110
PMCPMC1850678
OpenAlexW131017153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.